FDA Recall Terminated Historical recordClass III
ANORO ELLIPTA (umeclidinium and vilanterol inhalation powder) 62.5 mcg/25mcg. 1 inhaler contains 30 doses (60 blisters total), Rx Only, Manufactured by GlaxoSmithKline Durham, NC 27701. NDC 0173-0869-10
- Reason
- Failed Release Testing: Coarse Particle Mass for umeclidinium Out of Specification
- Published
- January 3, 2024
- Distribution
- Nationwide
